Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 2 |
2022 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
chouahda z[au]
(1 results)?
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.
Eur J Immunol. 2021 Jan;51(1):180-190. doi: 10.1002/eji.202049058. Epub 2020 Dec 23.
Eur J Immunol. 2021.
PMID: 33259646
Free PMC article.
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study.
Launay O, Artaud C, Lachâtre M, Ait-Ahmed M, Klein J, Luong Nguyen LB, Durier C, Jansen B, Tomberger Y, Jolly N, Grossmann A, Tabbal H, Brunet J, Gransagne M, Choucha Z, Batalie D, Delgado A, Müllner M, Tschismarov R, Berghmans PJ, Martin A, Ramsauer K, Escriou N, Gerke C.
Launay O, et al. Among authors: choucha z.
EBioMedicine. 2022 Jan;75:103810. doi: 10.1016/j.ebiom.2021.103810. Epub 2022 Jan 16.
EBioMedicine. 2022.
PMID: 35045362
Free PMC article.
Clinical Trial.
Item in Clipboard
Production and characterization of a fusion form of hepatitis E virus tORF2 capsid protein in Escherichia coli.
Boumaiza M, Trabelsi K, Choucha Z, Akrouti I, Leone S, Picone D, Kallel H.
Boumaiza M, et al. Among authors: choucha z.
Prep Biochem Biotechnol. 2021;51(6):562-569. doi: 10.1080/10826068.2020.1836656. Epub 2020 Oct 23.
Prep Biochem Biotechnol. 2021.
PMID: 33095097
Item in Clipboard
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
Brunet J, Choucha Z, Gransagne M, Tabbal H, Ku M-W, Buchrieser J, Fernandes P, Batalie D, Lopez J, Ma L, Dufour E, Simon E, Hardy D, Petres S, Guinet F, Strick-Marchand H, Monot M, Charneau P, Majlessi L, Duprex WP, Gerke C, Martin A, Escriou N.
Brunet J, et al. Among authors: choucha z.
J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693-23. Online ahead of print.
J Virol. 2024.
PMID: 38563763
Free article.
Item in Clipboard
Cite
Cite